Qoraa: Gregory Harris
Taariikhda Abuurista: 14 Abriil 2021
Taariikhda Cusboonaysiinta: 18 Noofeembar 2024
Anonim
Mode of action of Saccharomyces boulardii CNCM I-745
Dareemoleyad: Mode of action of Saccharomyces boulardii CNCM I-745

Qanacsan

Saccharomyces boulardii waa khamiir. Waxaa horey loogu aqoonsaday inuu yahay nooc khamiir khaas ah. Hadda waxaa la rumeysan yahay inuu yahay nooc ka mid ah cudurka 'Saccharomyces cerevisiae'. Laakiin Saccharomyces boulardii wuu ka duwan yahay noocyada kale ee Saccharomyces cerevisiae oo badanaa loo yaqaan khamiirka brewer iyo khamiirka rootiga. Saccharomyces boulardii waxaa loo isticmaalaa daawo ahaan.

Saccharomyces boulardii waxaa badanaa loo isticmaalaa daaweynta iyo ka hortagga shubanka, oo ay ku jiraan noocyada faafa sida shuban-biyoodka rotaviral ee carruurta. Waxay leedahay xoogaa caddayn ah oo loogu talagalay noocyada kale ee shubanka, finanka, iyo infekshinka mareenka dheef-shiidka oo u horseedi kara nabarro.

Cudurka Coronavirus 2019 (COVID-19): Ma jirto caddeyn wanaagsan oo lagu taageerayo isticmaalka Saccharomyces boulardii ee loogu talagalay COVID-19. Raac xulashooyinka hab-nololeedka caafimaadka qaba iyo hababka kahortagga ee la xaqiijiyay.

Daawooyinka Dabiiciga ah ee Xogta Dhamaystiran waxay qiimeysaa waxtarka ku saleysan caddeynta sayniska iyadoo loo eegayo cabirka soo socda: Wax ku ool ah, Suurta gal ah inuu wax ku ool yahay, suurtagal tahay wax ku ool ah, macquul ahaan waxtar la'aan, suurtagal ahaan waxtar la'aan, waxtar la'aan, iyo caddayn ku filan oo lagu qiimeeyo.

Qiimeynta waxtarka ee SACCHAROMYCES BOULARDII waa sida soo socota:


Waxtar u leh ...

  • Shuban. Cilmi baaris ayaa muujisay in la siiyo carruurta qaba shuban biyoodka 'Saccharomyces boulardii' ay yareyn karto inta ay soconeyso illaa 1 maalmood. Laakiin Saccharomyces boulardii waxay umuuqataa inay ka waxtar yartahay dawooyinka caadiga ah ee shubanka, sida loperamide (Imodium).
  • Shuban uu sababo rotavirus. Bixinta Saccharomyces boulardii ee dhallaanka iyo carruurta qaba shuban-biyoodka uu sababo rotafayruusku waxay yareyn kartaa inta uu shubanku soconayo illaa 1 maalmood.

Suurtagal inay wax ku ool u tahay ...

  • Finanka. Cilmi baaris ayaa muujisay in qaadashada Saccharomyces boulardii ee afka ay ka caawiso hagaajinta muuqaalka finanka.
  • Shuban ku dhaca dadka qaata antibiyootikada (shuban-biyoodka la xiriira antibiyootigga). Cilmi baarista badankeedu waxay muujineysaa in Saccharomyces boulardii ay gacan ka geysan karto kahortagga shubanka ku dhaca dadka waaweyn iyo carruurta lagu daweeyo antibayootigyada. Bukaan kasta oo 9-13 ah oo lagu daaweeyo Saccharomyces boulardii inta lagu guda jiro daaweynta antibiyootigyada, hal qof ayaa ka yar ayaa ku dhici doona shuban la xiriira antibiyootig.
  • Infekshinka marinka caloosha iyo bakteeriyada loo yaqaan Clostridium wuya. Qaadashada Saccharomyces boulardii oo ay weheliso antibayootigyada ayaa umuuqda inay gacan ka geysaneyso kahortagga shuban-biyoodka Clostridium ee dhibaatooyinka la xiriira inuu ku soo noqnoqdo dadka taariikh u leh soo noqoshada. Qaadashada Saccharomyces boulardii oo ay weheliso antibiyootiko sidoo kale waxay umuuqataa inay gacan ka geysaneyso kahortagga dhacdooyinka ugu horreeya ee shuban-biyoodka la xiriira Clostridium. Laakiin khubaradu kuma talinayaan isticmaalka Saccharomyces si looga hortago dhacdooyinka ugu horreeya.
  • Caabuq ku dhaca mareenka dheef-shiidka oo u horseedi kara nabarro (Helicobacter pylori ama H. ​​pylori). Qaadashada Saccharomyces boulardii afka oo ay weheliso daaweynta H. H. pylori ee caadiga ah waxay ka caawisaa daaweynta cudurkaan. Qiyaastii 12 qof ayaa u baahan in lagu daweeyo Saccharomyces boulardii oo dheeraad ah oo loogu talagalay hal bukaan oo haddii kale ku dhici lahaa cudurka si loo bogsiiyo. Qaadashada Saccharomyces boulardii sidoo kale waxay ka caawisaa ka hortagga dhibaatooyinka soo raaca sida shubanka iyo lallabbada ku dhaca daaweynta H. pylori ee caadiga ah. Tani waxay ka caawin kartaa dadka inay dhammeeyaan daaweyntooda caadiga ah ee H. pylori.
  • Shuban ku dhaca dadka qaba HIV / AIDS. Qaadashada Saccharomyces boulardii ee afka waxay umuuqataa inay yareynayso shubanka la xiriira HIV.
  • Cudur xiidmaha oo halis ah oo ku dhaca dhallaanka dhiciska ah (necrotizing enterocolitis ama NEC). Baadhitaanada badankood waxay muujinayaan in bixinta Saccharomyces boulardii ee dhallaanka uurka ka hor ay ka hortagto NEC.
  • Cudurka shubanka ee socotada. Qaadashada boulardii ee Saccharomyces waxay u muuqataa inay ka hortageyso shubanka safarka.

Suurtagal ma ahan waxtar ...

  • Caabuqa dhiigga (sepsis). Cilmi baaris ayaa muujisay in siinta Saccharomyces boulardii dhallaanka uurka ku jira, aysan ka hortegeynin sepsis.

Cadeymo aan ku filneyn in lagu qiimeeyo wax ku oolnimada ...

  • Infekshan ku dhaca xiidmaha oo sababa shuban (daacuun). Saccharomyces boulardii uma muuqato inay hagaajineyso calaamadaha daacuunka, xitaa marka lagu siiyo daweynta caadiga ah.
  • Xusuusta iyo xirfadaha fekerka (shaqada garashada). Daraasad hore waxay muujisay qaadashada Saccharomyces boulardii inaysan ka caawinayn ardayda inay ku fiicnaadaan imtixaannada ama ay yareeyaan buufiskooda.
  • Nooc ka mid ah cudurada mindhicirka ee caabuqa (Crohn disease). Qaadashada Saccharomyces boulardii waxay umuuqataa inay yareyneyso tirada dhaqdhaqaaqa caloosha ee dadka qaba cudurka Crohn. Daraasad hore waxay sidoo kale muujineysaa qaadashada Saccharomyces boulardii oo ay weheliso mesalamine waxay ka caawin kartaa dadka qaba cudurka Crohn inay muddo dheer ku maqnaadaan. Laakiin qaadashada Saccharomyces boulardii kaligeed uma muuqato inay ka caawinayso dadka qaba cudurka Crohn inay sii dheeraadaan ka-noqoshada.
  • Cudurka 'Cystic fibrosis'. Cilmibaaris hore waxay muujisay qaadashada Saccharomyces boulardii ee afka inaysan yareynaynin infekshannada khamiirka ee habka dheef-shiidka ee dadka qaba cystic fibrosis.
  • Wadne istaag. Daraasad hore waxay muujineysaa in qaadashada Saccharomyces boulardii ay wanaajin karto shaqada wadnaha ee dadka wadnaha istaaga.
  • Kalastarol sare. Cilmibaaristii ugu horreysay waxay muujineysaa in Saccharomyces boulardii aysan u muuqan inay saameyn ku yeelanayso heerarka kolestaroolka.
  • Cilad muddo-dheer ah ee mindhicirada waaweyn ee sababa calool xanuun (cillad maskaxeed xanaaqsan ama IBS). Cilmi baaris ayaa muujisay qaadashada Saccharomyces boulardii inay wanaajineyso tayada nolosha dadka qaba shuban-biyoodka ama nooca isku-dhafan ee IBS. Laakiin Saccharomyces boulardii uma muuqato inay hagaajineyso inta badan calaamadaha IBS sida calool xanuun, deg deg, ama dibbiro.
  • Cudurka faafa ee mindhicirka by dulin. Daraasad hore waxay muujisay qaadashada Saccharomyces boulardii oo ay weheliso antibiyootiko waxay yareyneysaa shubanka iyo calool xanuunka dadka qaba infekshinka amoeba.
  • Jaalaha maqaarka ee dhallaanka (cagaarshowga dhalaanka). Dhallaanka qaarkood waxay yeeshaan cagaarshow ka dib dhalashada sababo la xiriira heerarka sare ee bilirubin. Bixinta Saccharomyces boulardii ee loogu talagalay dhallaanka ayaa laga yaabaa inay ka hortagto cagaarshowga waxayna yareyneysaa baahida loo qabo daaweynta fototerapi ee tiro yar oo carruurtaan ka mid ah. Laakiin lama oga haddii Saccharomyces boulardii ay yareyneyso halista cagaarshowga ee carruurta halista ugu jirta. Bixinta Saccharomyces boulardii ee dhallaanka oo ay weheliso daawaynta fototherapy hoos uma dhigeyso heerarka bilirubin ee ka wanaagsan kan keliya ee loo yaqaan 'phototherapy'.
  • Dhallaanka ku dhashay miisaankoodu ka yar yahay 2500 garaam (5 rodol, 8 wiqiyadood). Bixinta kaabashka 'Saccharomyces boulardii' dhalashada dhalashada kadib waxay umuuqataa inay wanaajineyso kororka miisaanka iyo quudinta dhallaanka aan weli dhalan oo leh miisaan dhalasho oo hooseeya.
  • Kordhinta xad dhaafka ah ee bakteeriyada mindhicirada yar. Daraasad hore waxay muujisay in ku darista Saccharomyces boulardii ee daaweynta antibiyootigga ay yareyneyso koritaanka bakteeriyada mindhicirada oo ka wanaagsan antibiyootikada oo keliya.
  • Nooc ka mid ah cudurada mindhicirka oo barara (ulcerative colitis). Daraasad hore waxay muujisay in ku darista Saccharomyces boulardii ee daaweynta mesalamine-ka caadiga ah ay yareyn karto astaamaha dadka qaba ulcerative colitis-dhexdhexaad-ilaa-dhexdhexaad ah.
  • Nabarada nabarrada.
  • Qandho xummad leh.
  • Hilib.
  • Dulqaad la'aanta Laktose.
  • Cudurka Lyme.
  • Murqo xanuun oo jimicsiga ka dhasha.
  • Cudurrada kaadi mareenka (UTIs).
  • Caabuqa khamiirka.
  • Xaaladaha kale.
Cadeymo dheeraad ah ayaa loo baahan yahay si loogu qiimeeyo Saccharomyces boulardii isticmaalladan.

Saccharomyces boulardii waxaa lagu magacaabaa "probiotic," noole saaxiibtinimo leh oo gacan ka geysta la dagaallanka noolaha cudurrada keena ee ku jira xiidmaha sida bakteeriyada iyo khamiirka.

Markii afka lagaa qaado: Saccharomyces boulardii waa KU SOO DHAWEYN SAFE dadka waaweyn badankood marka afka la galiyo ilaa 15 bilood. Waxay ku keeni kartaa gaaska dadka qaarkood. Marar dhif ah, waxay sababi kartaa infekshannada fungal ee ku faafi kara qulqulka dhiigga ee jirka oo dhan (fungemia).

Taxaddarrada gaarka ah & digniinta:

Uurka iyo nuujinta: Ma jiro macluumaad ku filan oo lagu kalsoonaan karo oo lagu ogaan karo haddii Saccharomyces boulardii ay ammaan tahay in la isticmaalo marka uurka leedahay ama naaska la nuujinayo. Joog dhinaca aaminka ah iskana ilaali isticmaalka.

Caruurta: Saccharomyces boulardii waa BADBAADO KU SAABSAN carruurta markii afka looga qaato si habboon. Si kastaba ha noqotee, shubanka carruurta waa inuu qiimeeyaa xirfadlaha daryeelka caafimaad ka hor intaadan isticmaalin Saccharomyces boulardii.

Waayeel: Dadka waayeelka ah waxaa laga yaabaa inay yeeshaan halista sii kordheysa ee infekshanka fungal markay qaadanayaan Saccharomyces boulardii. Joog dhinaca aaminka ah iskana ilaali isticmaalka.

Difaaca jirka oo daciifa: Waxaa jira walaac xoogaa ah in qaadashada Saccharomyces boulardii ay sababi karto fungemia, taas oo ah joogitaanka khamiirka dhiiga. Tirada dhabta ah ee cudurka fungemia ee la xariira Saccharomyces boulardii way adagtahay in la ogaado. Si kastaba ha noqotee, halistu waxay u muuqataa inay ugu weyn tahay dadka aad u jiran ama kuwa daciifka u ah nidaamka difaaca jirka. Gaar ahaan, dadka qaba kateetarada, kuwa hela quudinta tubada, iyo kuwa lagu daaweeyo antibiyootiko badan ama antibiyootiko ka shaqeeya noocyo kala duwan oo infekshanno ah ayaa umuuqda kuwa halista ugu badan. Xaalado badan, fungemia waxaa ka dhasha wasakheynta hawo-mareenka hawada, sagxadaha deegaanka, ama gacmaha ku sumoobeen Saccharomyces boulardii.

Xasaasiyadda khamiirka: Dadka xasaasiyadda ku leh khamiirka waxay xasaasiyad ku yeelan karaan alaabooyinka ay ku jiraan Saccharomyces boulardii, waxaana ugu wanaagsan in lagula taliyo inay ka fogaadaan waxyaabahaas.

Yar
Ka taxaddar iskudhafkan.
Daawooyinka cudurada fungal (Antifungals)
Saccharomyces boulardii waa fungus. Daawooyinka cudurada fungal waxay caawiyaan yareynta fangaska gudaha iyo jirka. Qaadashada daawada loo yaqaan 'Saccharomyces boulardii' ee leh dawooyinka loogu talagalay infekshannada fungal waxay yareyn kartaa waxtarka Saccharomyces boulardii.
Daawooyinka qaar ee loogu talagalay infekshanka fungal waxaa ka mid ah fluconazole (Diflucan), caspofungin (Cancidas), itraconazole (Sporanox) amphotericin (Ambisome), iyo kuwo kale.
Ma jiraan is-dhexgal la yaqaan oo leh geedo iyo waxyaabo dheeri ah.
Ma jiraan wax la yaqaan oo la falgala cunnooyinka.
Qiyaasaha soo socda ayaa lagu bartay cilmi baarista sayniska:

DADKA WAAWEYN

AFKA:
  • Shuban biyoodka dadka qaata antibiyootikada (shuban-biyoodka la xiriira antibiyootikada): 250-500 mg of Saccharomyces boulardii oo la qaato 2-4 jeer maalin kasta ilaa 2 toddobaad ayaa badanaa la isticmaalaa. Xaaladaha badankood, qiyaasta maalinlaha ah kama badna 1000 mg maalin kasta.
  • Cudurka infekshinka marinka caloosha iyo bakteeriyada loo yaqaan Clostridium wuya: Si looga hortago soo noqoshada, 500 mg oo ah Saccharomyces boulardii laba jeer maalintii 4 usbuuc oo ay weheliso daaweynta antibiyootigga ayaa la isticmaalay.
  • Cudurka mareenka dheef-shiidka ee u horseedi kara nabarro (Helicobacter pylori ama H. ​​pylori): 500-1000 mg of Saccharomyces boulardii maalin kasta usbuucyada 1-4 inta badan waa la isticmaalaa.
  • Shuban-biyoodka ku dhaca dadka qaba HIV / AIDS: 3 garaam oo Saccharomyces boulardii maalin kasta.
  • Dadka safarka ah shuban-biyoodka: 250-1000 mg of Saccharomyces boulardii maalin kasta muddo 1 bilood ah.
CARRUURTA

AFKA:
  • Shuban biyoodka dadka qaata antibiyootikada (shuban-biyoodka la xiriira antibiyootikada): 250 mg oo Saccharomyces boulardii ah hal mar ama laba jeer maalintii mudada antibiyootikada ayaa la isticmaalay.
  • Shuban biyood: Daaweynta shuban-biyoodka ba'an, 250 mg oo Saccharomyces boulardii ah hal mar ama laba jeer maalintii ama 10 bilyan oo unug oo sameysma gumeystaha hal mar maalintii 5 maalmood ayaa la isticmaalay. Daaweynta shuban-biyoodka joogtada ah, 1750 bilyan ilaa 175 tirilyan oo unugyo sameys ah oo sameys ah oo loo yaqaan 'Saccharomyces boulardii' laba jeer maalintii 5 maalmood ayaa la isticmaalay. Si looga hortago shuban-biyoodka dadka qaata quudinta tubada, 500 mg oo Saccharomyces boulardii ah afar jeer maalintii ayaa la isticmaalay.
  • Shuban ka dhasha rotafayruusta: 200-250 mg mg Saccharomyces boulardii laba jeer maalintii 5 maalmood ayaa la isticmaali jiray.
  • Cudurka mindhicirka ee halista ah ee dhallaanka dhiciska ah (necrotizing enterocolitis ama NEC): 100-200 mg / kg Saccharomyces boulardii maalin kasta, laga bilaabo usbuuca koowaad dhalashada kadib.
Probiotic, Probiotique, Saccharomyces, Saccharomyces Boulardii CNCM I-745, Saccharomyces Boulardii HANSEN CBS 5926, Saccharomyces Boulardii Lyo CNCM I-745, Saccharomyces Boulardius, Saccharomyces Cerevisiae Boulardii, Cerevisiae HANSEN CBS 5926, Saccharomyces cerevisiae var boulardii, S. Boulardii, SCB.

Si aad wax badan uga ogaato sida maqaalkan loo qoray, fadlan eeg Daawooyinka Dabiiciga ah ee Xogta Dhamaystiran habka.


  1. Florez ID, Veroniki AA, Al Khalifah R, et al. Waxtarka isbarbardhigga iyo badbaadada waxqabadyada shuban-biyoodka ba'an iyo calool-mareenka carruurta: Dib-u-eegis nidaamsan iyo shabakad falanqeyn ku socota. QAADO Mid. 2018; 13: e0207701. Eeg aragti
  2. Harnett JE, Pyne DB, McKune AJ, Penm J, Pumpa KL. Kordhinta probiotic waxay keenaysaa isbeddello wanaagsan oo ku dhaca murqaha iyo tayada hurdada ee ciyaartoyda rugby. J Sci Med Sport. 2020: S1440-244030737-4. Eeg aragti
  3. Gao X, Wang Y, Shi L, Feng W, Yi K. Saamaynta iyo nabadgelyada Saccharomyces boulardii ee loogu talagalay carruurta necrotizing enterocolitis-ka ee dhallaanka xilliga hore: Dib-u-eegis nidaamsan iyo falanqayn meta ah. J Trop Pediatr. 2020: fmaa022. Eeg aragti
  4. Mourey F, Sureja V, Kheni D, iyo al. Tijaabooyin badan oo kala duwan, kala sooc ah, laba-indhoole ah, xakamaynta xakamaynta ah ah ee Saccharomyces boulardii ee dhallaanka iyo carruurta qaba shuban ba'an. Cudurka Carruurta Dis Dis J. J. 2020; 39: e347-e351. Eeg aragti
  5. Karbownik MS, Kr & eogon; czy & nacute; ska J, Kwarta P, et al. Saameynta kaabista ee Saccharomyces boulardii oo ku saabsan waxqabadka imtixaanka tacliinta iyo walbahaarka la xiriira ee ardayda caafimaadka caafimaadka leh: Maxkamad la kala soocay oo kala-duwan, laba-indhoole ah. Nafaqooyinka. 2020; 12: 1469. Eeg aragti
  6. Zhou BG, Chen LX, Li B, Wan LY, Ai YW. Saccharomyces boulardii oo ah daaweyn ku-meel-gaar ah oo loogu talagalay cirib-tirka Helicobacter pylori: Dib-u-eegis nidaamsan iyo falanqayn mood iyo falanqeyn isku xigxig ah oo tijaabo ah. Helicobacter. 2019; 24: e12651. Eeg aragti
  7. Szajewska H, ​​Kolodziej M, Zalewski BM. Dib-u-eegis nidaamsan oo lagu sameeyo falanqaynta maadada: Saccharomyces boulardii ee lagu daaweeyo caloosha daran ee carruurta - cusbooneysiinta 2020. Aliment Pharmacol Ther. 2020. Eeg aragti.
  8. Seddik H, Boutallaka H, ​​Elkoti I, iyo al. Saccharomyces boulardii CNCM I-745 oo lagu daray daaweyn isdaba-joog ah oo loogu talagalay infekshannada Helicobacter pylori: tijaabin tijaabo ah oo calaamadeysan. Eur J Clin Pharmacol. 2019; 75: 639-645. Eeg aragti
  9. García-Collinot G, Madrigal-Santillán EO, Martínez-Bencomo MA, iyo al. Waxtarka Saccharomyces boulardii iyo Metronidazole ee Bakteeriyada Yar ee Bakteeriyada ee Nidaamka Sclerosis. 2019. Eeg aragti.
  10. McDonald LC, Gerding DN, Johnson S, iyo al.; Bulshada Cudurada faafa ee Ameerika. Tilmaamaha tababarka caafimaadka ee loogu talagalay infekshanka Clostridium ee dhibaatooyinka dadka waaweyn iyo carruurta: cusbooneysiinta 2017 ee Ururka Cudurada Infekshinka ee Ameerika (IDSA) iyo Bulshada Caafimaadka Daryeelka Cudurrada ee Mareykanka (SHEA). Cudurrada faafa ee caafimaadka 2018; 66: e1-e48.
  11. Xu L, Wang Y, Wang Y, iyo al. Tijaabin laba-indho la 'oo la kala soocay oo ku saabsan koritaanka iyo u dulqaadashada quudinta ee leh Saccharomyces boulardii CNCM I-745 ee dhallaanka uurka ku jira ee caanaha ku jira. J Pediatr (Rio J). 2016; 92: 296-301. Eeg aragti
  12. Sheele J, Cartowski J, Dart A, et al. Saccharomyces boulardii iyo bismuth subsalicylate oo ah waxqabadyo qiimo jaban si loo yareeyo mudada iyo darnaanta daacuunka. Pathog Glob Caafimaadka. 2015; 109: 275-82. Eeg aragti
  13. Ryan JJ, Hanes DA, Schafer MB, Mikolai J, Zwickey H. Saamaynta Probiotic Saccharomyces boulardii ee Kalastaroolka iyo Qaybaha Lipoprotein-ka ee Dadka Waaweyn ee Hypercholesterolemic: Hal-Gacan, Daraasad Duuliye Furan. J Beddel Dheeri ah Med. 2015; 21: 288-93. Eeg aragti
  14. Flatley EA, Wilde AM, Nailor MD. Saccharomyces boulardii oo loogu talagalay kahortaga bilaabista isbitaalka infekshinka Clostridium wuya. J Gastrointestin Beerka Dis. 2015; 24: 21-4. Eeg aragti
  15. Ehrhardt S, Guo N, Hinz R, iyo al. Saccharomyces boulardii si looga Hortago Shuban-biyoodka La Xiriira Cudurka Shuban Biyoodka: Tijaabis La Sameeyay, Laba Waji-Maskeysan, Maxkamad Lagu Xakameeyo Goobta. Madasha Furan ee Caabuqa Dis. 2016; 3: ofw011. Eeg aragti
  16. Dinleyici EC, Kara A, Dalgic N, iyo al. Saccharomyces boulardii CNCM I-745 wuxuu yareynayaa muddada shubanka, dhererka daryeelka degdegga ah iyo joogitaanka isbitaalka ee carruurta qaba shuban ba'an. Microf Microbes. 2015; 6: 415-21. Eeg aragti
  17. Dauby N. Khatarta Saccharomyces boulardii-ay kujirto Probiotics ee Kahortaga Cudurka Clostridium ee Dadka Waayeelka ah. Gastroenterology. 2017; 153: 1450-1451. Eeg aragti
  18. Cottrell J, Koenig K, Perfekt R, Hofmann R; Kooxda Daraasada Cudurka Shuban Biyoodka Loperamide-Simethicone. Isbarbardhigga laba nooc oo ah Loperamide-Simethicone iyo Khamiir Probiotic ah (Saccharomyces boulardii) ee Daaweynta Shuban-biyoodka Ba'an ee Dadka Waaweyn: Tijaabo Caafimaad oo aan Xunayn oo Xanuunsan. Daawooyinka R D. 2015; 15: 363-73. Eeg aragti
  19. Costanza AC, Moscavitch SD, Faria Neto HC, Mesquita ET. Daaweynta loo yaqaan 'Probiotic therapy' ee loo yaqaan 'Saccharomyces boulardii' ee loogu talagalay bukaanka wadnaha oo istaaga: tijaabin tijaabo tijaabo ah oo laba-indhoole ah. Int J Cardiol. 2015; 179: 348-50. Eeg aragti
  20. Carstensen JW, Chehri M, Schønning K, iyo al. Isticmaalka daawada loo yaqaan 'Saccharomyces boulardii' oo looga hortago infekshinka Clostridium ee dhibaatooyinka bukaan-jiifka la dhigo: daraasad wax ka qabashada mustaqbalka la xakameynayo. Eur J Clin Microbiol Infekshinka Dis. 2018; 37: 1431-1439. Eeg aragti
  21. Asmat S, Shaukat F, Asmat R, Bakhat HFSG, Asmat TM. Isbarbardhiga Waxtarka Caafimaadka ee Saccharomyces Boulardii iyo Lactic Acid sida Probiotics ee Shuban-biyoodka Ba'an. J Coll Dhakhaatiirta Surg Pak. 2018; 28: 214-217. Eeg aragti
  22. Remenova T, Morand O, Amato D, Chadha-Boreham H, Tsurutani S, Marquardt T. Laba-indhoole, la kala soocay, tijaabinta xakamaynta xakamaynta oo lagu baranayo saamaynta Saccharomyces boulardii ee dulqaadashada caloosha, badbaadada, iyo dawooyinka daawooyinka ee miglustat. Orphanet J Rare Dis 2015; 10: 81. Eeg aragti
  23. Suganthi V, Das AG. Doorka Saccharomyces boulardii ee dhimista hyperbilirubinemia dhalaanka. J Clin Diagn Qaraarka 2016; 10: SC12-SC15. Eeg aragti
  24. Riaz M, Alam S, Malik A, Ali SM. Waxtarka iyo badbaadada Saccharomyces boulardii ee shuban-biyoodka ba'an: waa laba-indho la'aan tijaabin kontorool ah. Hindida J Pediatr 2012; 79: 478-82. Eeg aragti
  25. - Corrêa NB, Penna FJ, Lima FM, Nicoli JR, Filho LA. Daaweynta shuban-biyoodka ba'an ee loo yaqaan 'Saccharomyces boulardii' ee dhallaanka. J Pediatr Gastroenterol Nutr 2011; 53: 497-501. Eeg aragti
  26. Cohen SH, Gerding DN, Johnson S, iyo al.; Bulshada Daryeelka Caafimaadka Epidemiology ee Mareykanka; Bulshada Cudurada faafa ee Ameerika. Tilmaamaha tababarka caafimaadka ee loogu talagalay infekshanka Clostridium ee dhibaatooyinka dadka waaweyn: 2010 cusbooneysiinta bulshada ee daryeelka cudurrada faafa ee Mareykanka (SHEA) iyo bulshada cudurada faafa ee Mareykanka (IDSA). Xakamaynta Caabuqa Hosp Epidemiol 2010; 31: 431-55. Eeg aragti
  27. Goldenberg JZ, Ma SS, Saxton JD, iyo al. Daawada loo adeegsado kahortaga shuban-biyoodka ku xiran Clostridium ee dadka waaweyn iyo carruurta. Macluumaadka Cochrane Syst Rev. 2013;: CD006095. Eeg aragti
  28. Lau CS, Chamberlain RS. Probiotics-ku wuxuu waxtar u leeyahay ka hortagga shuban-biyoodka la xiriira Clostridium: dib-u-eegis nidaamsan iyo falanqayn metaleed. Int J Gen Med. 2016; 9: 27-37. Eeg aragti
  29. Roy U, Jessani LG, Rudramurthy SM, iyo al. Toddobo kiis oo Saccharomyces fungaemia ah oo la xiriira isticmaalka probiotics. Maqnaanshaha 2017; 60: 375-380. Eeg aragti
  30. Romanio MR, Coraine LA, Maielo VP, Abramczyc ML, Souza RL, Oliveira NF. Saccharomyces cerevisiae fungemia ee bukaan socodka carruurta ka dib daaweynta probiotics. Rev Paul Pediatr 2017; 35: 361-4. Eeg aragti
  31. Pozzoni P, Riva A, Bellatorre AG, iyo al. Saccharomyces boulardii ee ka hortagga shuban-biyoodka la xiriira antibiyootikada ee bukaannada qaan-gaarka ah ee la seexiyay: hal xarun, kala-sooc ah, laba-indhoole ah, tijaabo ah xakamaynta placebo. Am J Gastroenterol 2012; 107: 922-31. Eeg aragti
  32. Martin IW, Tonner R, Trivedi J, iyo al. Saccharomyces boulardii probiotic-associated fungemia: su'aal ka qabta badbaadada isticmaalka kahortaga probiotic. Diagn Microbiol Infekshanka Dis. 2017; 87: 286-8. Eeg aragti
  33. Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ. Tijaabinta, laba-indhoole, tijaabinta xakamaynta xuduudaha ee Saccharomyces boulardii ee cilladda mindhicirka xanaaqa: saameynta tayada nolosha. J Clin Gastroenterol. 2011; 45: 679-83. Eeg aragti
  34. Atici S, Soysal A, Karadeniz Cerit K, iyo al. Catchater-la xiriira Saccharomyces cerevisiae Fungemia Ka dib Saccharomyces boulardii Daaweynta Probiotic: Ilmaha ku jira qaybta daryeelka degdegga ah iyo dib u eegista suugaanta. Kiiska Med Mycol Kiiska. 2017; 15: 33-35. Eeg aragti
  35. Appel-da-Silva MC, Narvaez GA, Perez LRR, Drehmer L, Lewgoy J. Saccharomyces cerevisiae var. boulardii fungemia ka dib daaweynta probiotic. Kiiska Med Mycol Case Rep. 2017; 18: 15-7. Eeg aragti
  36. Chang HY, Chen JH, Chang JH, Lin HC, Lin CY, Peng CC. Noocyo badan oo noocyada probiotics ah ayaa u muuqda kuwa ugu waxtarka badan ee ka hortagga necrotizing enterocolitis iyo dhimashada: Falanqeyn metaed oo la cusbooneysiiyay. QAADO Mid. 2017; 12: e0171579. Eeg aragti
  37. Blaabjerg S, Artzi DM, Aabenhus R. Probiotics ee Ka Hortagga Shubanka Antibiyootikada-La Xiriira Bukaan-socodka Bukaannada-Dib-u-eegis Nidaam iyo Meta-Analysis. Antibiyootikada (Basel). 2017; 6. Eeg aragti
  38. Al Faleh K, Anabrees J. Probiotics ee ka hortagga necrotizing enterocolitis ee dhallaanka uurka ku jira. Macluumaadka Cochrane Syst Rev. 2014;: CD005496. Eeg aragti
  39. Das S, Gupta PK, Das RR. Waxtarka iyo Badbaadada Saccharomyces boulardii ee Cudurka Shuban Biyoodka Ba'an: Laba Indhoole oo Indho-indhayn ah oo Loogu Tala Galay Waddanka Soo koraya. J Trop Pediatr. 2016; 62: 464-470. Eeg aragti
  40. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Daawada loo adeegsado kahortaga cudurka shuban biyoodka ee la xiriira antibiyootikada. Macluumaadka Cochrane Syst Rev. 2015;: CD004827. Eeg aragti
  41. Feizizadeh S, Salehi-Abargouei A, Akbari V. Waxtarka iyo badbaadada Saccharomyces boulardii ee shuban ba'an. Dhakhaatiirta carruurta. 2014; 134: e176-191. Eeg aragti
  42. Szajewska H, ​​Horvath A, Kolodziej M. Dib-u-eegis habeysan oo lagu sameeyo falanqaynta maadada: Kaabista iyo ka takhalusidda cudurka 'Saccharomyces boulardii' iyo baabi'inta infekshanka Helicobacter pylori. Aliment Pharmacol Ther. 2015; 41: 1237-1245. Eeg aragti
  43. Szajewska H, ​​Kolodziej M. Dib-u-eegis nidaamsan oo lala yeesho falanqaynta maadada: Saccharomyces boulardii ee ka hortagga cudurka shubanka ee loo yaqaan 'antibiyootikada'. Aliment Pharmacol Ther. 2015; 42: 793-801. Eeg aragti
  44. Ellouze O, Berthoud V, Mervant M, Parthiot JP, Girard C. Naxdin Septic ah sababa Sacccaromyces boulardii. Cudurka Med Mal Infect. 2016; 46: 104-105. Eeg aragti
  45. Bafutto M, iyo al. Daaweynta shuban-biyoodka caloosha xanaaqa leh ee mesalamine iyo / ama Saccharomyces boulardii. Arq Gastroenterol. 2013; 50: 304-309. Eeg aragti
  46. Bourreille A, iyo al. Saccharomyces boulardii kama hortageyso soo noqoshada cudurka Crohn. Clin Gastroenterol Hepatol. 2013; 11: 982-987.
  47. Serce O, Gursoy T, Ovali F, Karatekin G. Saamaynta Saccaromyces boulardii ee ku saabsan dhallaanka hyperbilirubinemia dhalashada: maxkamad la kantaroolay oo la kala sooco. Am J Perinatol. 2015; 30: 137-142. Eeg aragti
  48. Videlock EJ, Cremonini F. Meta-analysis: probiotics ee shuban-biyoodka la xiriira antibiyootikada. Aliment Pharmacol Ther. 2012; 35: 1355-69. Eeg aragti
  49. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Probiotics-ka loogu talagalay ka-hortagga iyo daaweynta shuban-biyoodka la xiriira: dib-u-eegis nidaamsan iyo falanqayn meta. JAMA. 2012 9; 307: 1959-69. Eeg aragti
  50. Elmer GW, Moyer KA, Vega R, iyo et al. Qiimeynta Saccharomyces boulardii ee loogu talagalay bukaannada qaba shuban-biyoodka ba'an ee la xiriira HIV iyo mutadawiciin caafimaad qaba oo qaata antifungals. Microecology Ther 1995; 25: 23-31.
  51. Potts L, Lewis SJ, iyo Barry R. Daraasad laba-indho-indhoole indho la'aan ah oo la xakameynayo oo ku saabsan awoodda Saccharomyces boulardii si looga hortago shuban-biyoodka la xiriira antibiyootigga [abstract]. Guut 1996; 38 (alaabada 1): A61.
  52. Bleichner G iyo Blehaut H. Saccharomyces boulardii waxay ka hortageysaa shuban-biyoodka bukaanka tubbo-xumada daran ku jira. Tijaabooyin badan oo kala-duwan, kala-sooc ah, indho-indhoole ah oo lagu xakameeyo placebo [abstract]. Clin Nutr 1994; 13 Cuntada 1:10.
  53. Maupas JL, Champemont P, iyo Delforge M. [Daaweynta cilladda mindhicirka ee xanaaqa leh ee Saccharomyces boulardii - waa laba-indhoole, daraasad xakamaynta placebo]. Médicine et Chirurgie Digestives 1983; 12: 77-79.
  54. Saint-Marc T, Blehaut H, Musial C, iyo et al. [Shuban-biyoodka la xiriira cudurka AIDS-ka: waa tijaabo laba-indhoole ah oo loo yaqaan 'Saccharomyces boulardii]. Semaine Des Hopitaux 1995; 71 (23-24): 735-741.
  55. McFarland LV, Surawicz C, Greenberg R, iyo et al. Saccharomyces boulardii iyo qiyaasta sare ee loo yaqaan 'vancomycin' waxay daaweeyaan cudurka Clostridium wuya ee soo noqnoqda [abstract]. Am J Gastroenterol 1998; 93: 1694.
  56. Chouraqui JP, Dietsch J, Musial C, iyo et al. Saccharomyces boulardii (SB) ee maaraynta shubanka socod baradka: daraasad laba-indho-indho-indheyn ah oo la xakameeyey [abstract]. J Pediatr Gastroenterol Nutr 1995; 20: 463.
  57. Cetina-Sauri G iyo Basto GS. Evaluacion terapeutica de Saccharomyces boulardii en ninos con diarrea aguda. Tribuna Med 1989; 56: 111-115.
  58. Adam J, Barret C, Barret-Bellet A, iyo et al. Essais cliniques controles en double insu de l’Ultra-Levure Lyophilisee. Etude multicentrique par 25 medecins de 388 cas. Gaz Med Fr 1977; 84: 2072-2078.
  59. McFarland LV, SurawiczCM, Elmer GW, iyo et al. Falanqaynta kaladuwan ee waxtarka caafimaad ee wakiilka biotherapeutic, Saccharomyces boulardii ee kahortaga shuban-biyoodka la xiriira antibiyootigga [abstract]. Am J Epidemiol 1993; 138: 649.
  60. Saint-Marc T, Rossello-Prats L, iyo Touraine JL. [Waxtarka Saccharomyces boulardii ee maaraynta cudurka shubanka AIDS]. Ann Med Interne (Paris) 1991; 142: 64-65.
  61. Kirchhelle, A., Fruhwein, N., iyo Toburen, D. [Daaweynta shubanka joogtada ah ee S. boulardii ee safrayayaasha soo noqonaya. Natiijooyinka daraasadda la filayo]. Fortschr Med 4-20-1996; 114: 136-140. Eeg aragti
  62. Dhashay, P., Lersch, C., Zimmerhackl, B., iyo Classen, M. [Daaweynta Saccharomyces boulardii ee shuban-biyoodka la xiriira]. Dtsch Med Wochenschr 5-21-1993; 118: 765. Eeg aragti
  63. Kollaritsch, H., Holst, H., Grobara, P., iyo Wiedermann, G. [Ka hortagga shubanka socdaalka ee qaba Saccharomyces boulardii. Natiijooyinka a placebo gacanta ku haynta daraasad laba-indhoole ah]. Fortschr.Med 3-30-1993; 111: 152-156. Eeg aragti
  64. Tempe, J. D., Steidel, A. L., Blehaut, H., Hasselmann, M., Lutun, P., iyo Maurier, F. [Kahortagga shubanka ee maamula Saccharomyces boulardii inta lagu gudajiray quudinta xubnaha jirka]. Sem.Hop. 5-5-1983; 59: 1409-1412. Eeg aragti
  65. Chapoy, P. [Daaweynta shuban-biyoodka ba'an: tijaabinta la xakameynayo ee Saccharomyces boulardii]. Ann Pediatr. (Paris) 1985; 32: 561-563. Eeg aragti
  66. Kimmey, M. B., Elmer, G. W., Surawicz, C. M., iyo McFarland, L. V. Kahortagga soo noqnoqoshada Clostridium wuya colitis oo leh Saccharomyces boulardii. Dig.Dis Sci 1990; 35: 897-901. Eeg aragti
  67. Saint-Marc, T., Rossello-Prats, L., iyo Touraine, J. L. [Waxtarka Saccharomyces boulardii ee daaweynta shubanka ee AIDS]. Ann Med Interne (Paris) 1991; 142: 64-65. Eeg aragti
  68. Duman, DG, Bor, S., Ozutemiz, O., Sahin, T., Oguz, D., Istan, F., Vural, T., Sandkci, M., Isksal, F., Simsek, I., Soyturk , M., Arslan, S., Sivri, B., Soykan, I., Temizkan, A., Bessk, F., Kaymakoglu, S., iyo Kalayc, C. Waxtarka iyo badbaadada Saccharomyces boulardii ee kahortaga antibiyootig- shuban la xiriira ciribtirka Helicobacterpylori. Eur J Gastroenterol.Hepatol. 2005; 17: 1357-1361. Eeg aragti
  69. Surawicz, C. M. Daaweynta cudurka soo noqnoqda ee la xiriira Clostridium. Nat Clin Pract.Gastroenterol.Hepatol. 2004; 1: 32-38. Eeg aragti
  70. Kurugol, Z. iyo Koturoglu, G. Saamaynta Saccharomyces boulardii ee carruurta qaba shuban ba'an. Acta Paediatr. 2005; 94: 44-47. Eeg aragti
  71. Kotowska, M., Albrecht, P., iyo Szajewska, H. Saccharomyces boulardii ee ka hortagga shuban-biyoodka antibiyootigga la xiriira ee carruurta: tijaabinta xakamaynta xakamaynta xakamaynta laba-indhoole. Aliment. Pharmacol. Halkaana. 3-1-2005; 21: 583-590. Eeg aragti
  72. Cherifi, S., Robberecht, J., iyo Miendje, Y. Saccharomyces cerevisiae fungemia bukaanka waayeelka ah ee qaba cudurka loo yaqaan 'Clostridium hardile colitis'. Acta Clin Belg. 2004; 59: 223-224. Eeg aragti
  73. Erdeve, O., Tiras, U., iyo Dallar, Y. Saamaynta probiotic ee Saccharomyces boulardii ee kooxda da'da carruurta. J Trop.Pediatr. 2004; 50: 234-236. Eeg aragti
  74. Costalos, C., Skouteri, V., Gounaris, A., Sevastiadou, S., Triandafilidou, A., Ekonomidou, C., Kontaxaki, F., iyo Petrochilou, V. Quudinta is-dhexgalka ee dhallaanka dhiciska ah ee leh Saccharomyces boulardii. Hore Hum.Dev. 2003; 74: 89-96. Eeg aragti
  75. Gaon, D., Garcia, H., Winter, L., Rodriguez, N., Quintas, R., Gonzalez, S. N., iyo Oliver, G. Saamaynta noocyada Lactobacillus iyo Saccharomyces boulardii oo ku saabsan shuban joogto ah oo carruurta ku dhaca. Medicina (B Aires) 2003; 63: 293-298. Eeg aragti
  76. Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K., iyo Shafaghi, A. Wax ku oolnimada saccharomyces boulardii oo leh antibiyootiko amoebiasis daran. World J Gastroenterol. 2003; 9: 1832-1833. Eeg aragti
  77. Riquelme, A. J., Calvo, M. A., Guzman, A.M., Depix, M. S., Garcia, P., Perez, C., Arrese, M., iyo Labarca, J. A. Saccharomyces cerevisiae fungemia kadib daaweynta Saccharomyces boulardii ee bukaanada difaaca jirka. J Clin Gastroenterol. 2003; 36: 41-43. Eeg aragti
  78. Cremonini, F., Di Caro, S., Santarelli, L., Gabrielli, M., Candelli, M., Nista, EC, Lupascu, A., Gasbarrini, G., iyo Gasbarrini, A. Probiotics-ka ku jira antibiyootig la xiriira shuban. Dig.Liver Dis. 2002; 34 Qalabka 2: S78-S80. Eeg aragti
  79. Lherm, T., Monet, C., Nougiere, B., Soulier, M., Larbi, D., Le Gall, C., Caen, D., iyo Malbrunot, C. Toddoba kiis oo fungemia ah oo leh Saccharomyces boulardii si xasaasi ah bukaanka jiran. Intensive Care Med 2002; 28: 797-801. Eeg aragti
  80. Tasteyre, A., Barc, M. C., Karjalainen, T., Bourlioux, P., iyo Collignon, A. Ka-hortagga u-hoggaansanaanta unugyada ku jira fitamiinnada ee loo yaqaan 'Clostridium wuya' ee Saccharomyces boulardii. Microb. Pathog. 2002; 32: 219-225. Eeg aragti
  81. Shanahan, F. Probiotics-ka oo ku jira cudurka mindhicirka oo barara. Guut 2001; 48: 609. Eeg aragti
  82. Surawicz, CM, McFarland, LV, Greenberg, RN, Rubin, M., Fekety, R., Mulligan, ME, Garcia, RJ, Brandmarker, S., Bowen, K., Borjal, D., iyo Elmer, GW The raadso daaweyn kafiican cudurka soo noqnoqda ee loo yaqaan 'Clostridium wuya': isticmaalka dawada sare ee loo yaqaan 'vancomycin' oo ay weheliso Saccharomyces boulardii. Clin.Infect.Dis. 2000; 31: 1012-1017. Eeg aragti
  83. Johnston BC, Ma SSY, Goldenberg JZ, et al. Daawada loo adeegsado kahortaga shuban biyoodka la xiriira Clostridium. Ann Intern Med 2012; 157: 878-8. Eeg aragti
  84. Munoz P, Bouza E, Cuenca-Estrella M, iyo al. Saccharomyces cerevisiae fungemia: waa cudur faafa oo soo ifbaxaya. Clin Infect Dis 2005; 40: 1625-34. Eeg aragti
  85. Szajewska H, ​​Mrukowicz J. Meta-analysis: khamiirka aan cudurada lahayn ee Saccharomyces boulardii ee ka hortagga shuban-biyoodka la xidhiidha antibiyootigga. Aliment Pharmacol Ther 2005; 22: 365-72. Eeg aragti
  86. M, Besirbellioglu BA, Avci IY, iyo al. Prophylactic Saccharomyces boulardii ee ka hortagga shuban-biyoodka la xiriira: Daraasad mustaqbalka ah. Monit Medit 2006; 12: PI19-22. Eeg aragti
  87. Guslandi M, Giollo P, Testoni PA. Tijaabo tijaabo ah oo loo yaqaan 'Saccharomyces boulardii' oo ku taal ulcerative colitis. Eur J Gastroenterol Hepatol 2003; 15: 697-8. Eeg aragti
  88. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii ee daaweynta dayactirka cudurka Crohn. Dig Dis Sci 2000; 45: 1462-4. Eeg aragti
  89. McFarland LV. Falanqaynta Meta-ka ee probiotics ee loogu talagalay kahortagga shubanka antibiyootikada la xiriira iyo daaweynta cudurka Clostridium wuya. Am J Gastroenterol 2006; 101: 812-22. Eeg aragti
  90. Marteau P, Seksik P. Dulqaadka probiotics iyo prebiotics. J Clin Gastroenterol 2004; 38: S67-9. Eeg aragti
  91. Borriello SP, Hammes WP, Holzapfel W, iyo al. Badbaadada daawada probiotics ee ay ku jiraan lactobacilli ama bifidobacteria. Clin Infect Dis 2003; 36: 775-80. Eeg aragti
  92. Cremonini F, Di Caro S, Covino M, et al. Saameynta diyaargarowga probiotic ee kaladuwan ee daaweynta anti-helicobacter pylori waxyeelada la xiriirta: koox isbarbar socota, indhoolayaal seddexaad ah, daraasad xakamaynta placebo. Am J Gastroenterol 2002; 97: 2744-9. Eeg aragti
  93. D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics ee ka hortagga cudurka shubanka ee la xiriira shubanka: falanqaynta maadada. BMJ 2002; 324: 1361. Eeg aragti
  94. Muller J, Remus N, Waxyeelada KH. Daraasada Mycoserological ee daaweynta bukaanka cystic fibrosis ee cudurada qaba Saccharomyces boulardii (Saccharomyces cerevisiae Hansen CBS 5926). Maqnaanshaha 1995; 38: 119-23. Eeg aragti
  95. Plein K, Hotz J. Saamaynta daaweynta ee Saccharomyces boulardii oo ku saabsan astaamaha khafiifka ah ee haraaga ah ee marxaladda xasilloon ee cudurka Crohn oo leh ixtiraam gaar ah oo ku saabsan shuban-ba'an - daraasad tijaabo ah. Z Gastroenterol 1993; 31: 129-34. Eeg aragti
  96. Hennequin C, Thierry A, Richard GF, et al. Qorista Microsatellite oo ah aalad cusub oo lagu aqoonsado noocyada 'Saccharomyces cerevisiae'. J Clin Microbiol 2001; 39: 551-9. Eeg aragti
  97. Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia bukaan neerofisiko ah oo lagu daaweeyay Saccharomyces boulardii Taageerada Kansarka Daryeelka 2000; 8: 504-5. Eeg aragti
  98. Weber G, Adamczyk A, Freytag S. [Daaweynta finanka leh diyaarinta khamiirka]. Fortschr Med 1989; 107: 563-6. Eeg aragti
  99. Lewis SJ, Freedman AR. Maqaalka dib u eegista: isticmaalka wakiilada biotherapeutic ee ka hortagga iyo daaweynta cudurka caloosha iyo mindhicirka. Aliment Pharmacol Ther 1998; 12: 807-22. Eeg aragti
  100. Krammer M, Karbach U. Waxqabadka shubanka ee khamiirka Saccharomyces boulardii ee jiirka xiidmaha yar iyo weyn iyadoo kicinaysa nuugista chloride. Z Gastroenterol 1993; 31: 73-7.
  101. Czerucka D, Roux I, Rampal P. Saccharomyces boulardii wuxuu xakameynayaa adenosine 3 ’, 5’-cyclic monophosphate induction in unugyada mindhicirka. Gastroenterol 1994; 106: 65-72. Eeg aragti
  102. Elmer GW, McFarland LV, Surawicz CM, iyo al. Habdhaqanka Saccharomyces boulardii ee bukaanka cudurka Clostridium ee soo noqnoqda. Aliment Pharmacol Ther 1999; 13: 1663-8. Eeg aragti
  103. Fredenucci I, Chomarat M, Boucaud C, iyo al. Saccharomyces boulardii fungemia bukaan qaata daaweyn heer sare ah. Clin Infect Dis 1998; 27: 222-3. Eeg aragti
  104. Pletinex M, Legein J, Vandenplas Y. Fungemia oo leh Saccharomyces boulardii oo ku jirta gabar 1-sano jir ah oo shuban-biyoodku sii dheeraanayo. J Pediatr Gastroenterol Nutr 1995; 21: 113-5. Eeg aragti
  105. Buts JP, Corthier G, Delmee M. Saccharomyces boulardii oo loogu tala galay Clostridium enteropathies ee laxiriira dhibaatooyinka dhallaanka. J Pediatr Gastroenterol Nutr 1993; 16: 419-25. Eeg aragti
  106. Surawicz CM, Elmer GW, Speelman P, iyo al. Ka-hortagga shubanka la xiriira antibiyootikada ee loo yaqaan 'Saccharomyces boulardii': daraasad la filayo. Gastroenterology 1989; 96: 981-8. Eeg aragti
  107. Surawicz CM, McFarland LV, Elmer G, iyo al. Daaweynta xanuunka loo yaqaan 'clostidium wuya' colitis ee soo noqnoqda oo leh vancomycin iyo Saccharomyces boulardii. Am J Gastroenterol 1989; 84: 1285-7. Eeg aragti
  108. McFarland LV, Surawicz CM, Greenberg RN, iyo al. Ka-hortagga shuban-biyoodka beta-lactam ee ay keento Saccharomyces boulardii marka la barbar dhigo placebo. Am J Gastroenterol 1995; 90: 439-48. Eeg aragti
  109. McFarland LV, Surawicz CM, Greenberg RN, iyo al. Tijaabinta xakamaynta xakamaynta xakamaynta ee Saccharomyces boulardii oo lagu daro antibiyootigyada caadiga ah ee cudurka Clostridium. JAMA 1994; 271: 1913-8. Eeg aragti
  110. Elmer GW, McFarland LV. Faallo ku saabsan la'aanta saameynta daaweynta ee Saccharomyces boulardii ee ka hortagga shubanka la xiriira antibiyootigga ee bukaanka waayeelka ah. J Cudurka 1998; 37: 307-8. Eeg aragti
  111. Lewis SJ, Potts LF, Barry RE. Dib-u-eegis Maqnaanshaha saameynta daaweynta ee Saccharomyces boulardii ee ka hortagga shubanka la xiriira antibiyootigga ee bukaanka waayeelka ah. J Cudurka 1998; 36: 171-4. Eeg aragti
  112. Bleichner G, Blehaut H, Mentec H, iyo al. Saccharomyces boulardii waxay ka hortagtaa shuban-biyoodka bukaannada tubbo-xumada daran ku jira. Intensive Care Med 1997; 23: 517-23. Eeg aragti
  113. Castagliuolo I, Riegler MF, Valenick L, et al. Saccharomyces boulardii protease waxay horjoogsataa saameynta sunta A iyo B ee ku dhaca xuubka xiidanka mindhicirka ee aadanaha. Caabuqa iyo Tallaalka 1999; 67: 302-7. Eeg aragti
  114. Saavedra J. Probiotics iyo shuban faafa. Am J Gastroenterol 2000; 95: S16-8. Eeg aragti
  115. McFarland LV. Saccharomyces boulardii maaha Saccharomyces cerevisiae. Clin Infect Dis 1996; 22: 200-1. Eeg aragti
  116. McCullough MJ, Clemons KV, McCusker JH, Stevens DA. Aqoonsiga Noocyada iyo sifooyinka isku-buuqa ee Saccharomyces boulardii (nom. Inval.). J Caafimaadka Microbiol 1998; 36: 2613-7. Eeg aragti
  117. Niault M, Thomas F, Prost J, iyo al. Fungemia oo ay ugu wacan tahay noocyada Saccharomyces ee bukaanka lagu daaweeyo xinjirta Saccharomyces boulardii. Clin Infect Dis 1999; 28: 930. Eeg aragti
  118. Bassetti S, Frei R, Zimmerli W. Fungemia oo leh Saccharomyces cerevisiae kadib daaweynta Saccharomyces boulardii. Am J Med 1998; 105: 71-2. Eeg aragti
  119. Scarpignato C, Rampal P. Ka-hortagga iyo daaweynta shuban-biyoodka socdaalka: Habka dawooyinka daaweynta. Chemotherapy 1995; 41: 48-81. Eeg aragti
Markii ugu dambeysay ee dib loo eegay - 11/10/2020

Caan Ah

Ma rumaysan doontid Jadwalka Skateboarding -ka Biyaha hoostiisa ee dabbaasha ee TikTok
Hab-Nololeed

Ma rumaysan doontid Jadwalka Skateboarding -ka Biyaha hoostiisa ee dabbaasha ee TikTok

Dabaa ha far haxanka Kri tina Maku henko kuma cu ba inay ku dhex maad ato dadweynaha barkadda, laakiin xagaagan, hibooyinkeeda ayaa oo jiitay dadkii badnaa TikTok. Laba jeer ku guulay tey bilad dahabi...
7 Arimood Oo Dadku Si Kala Duwan U Qabsadaan
Hab-Nololeed

7 Arimood Oo Dadku Si Kala Duwan U Qabsadaan

Waxaad oo martay waqtiyo ka badan intii aad daryeeli lahayd inaad tir ato: Markaad i ku daydo inaad maarey o walaacaaga ii kordhaya inta lagu jiro fowdada maalinta haqada ee ma hquulka ah, waxaa jira ...